THE ORBITROCK LIBRARY

Ear Disorders

An overview of conditions affecting the ear, hearing and balance, including causes, symptoms, diagnostic methods, treatment approaches and prognosis.

View download options

About this dataset

An overview of conditions affecting the ear, hearing and balance, including causes, symptoms, diagnostic methods, treatment approaches and prognosis.

Data preview

165records

12columns

CSV + Excel + JSONformats

Sample rows from Ear Disorders. Field types are labelled in each column heading.
#	TextNo.	TextDisease Name	TextCategory	TextPrimary Cause / Etiology	TextPrevalence	TextAge of Onset	TextKey Symptoms	TextAffected Organ(s)	TextDiagnostic Method	TextTreatment Approach	TextPrognosis	TextICD-10 Code
01	1	Auricular Keloid	External Ear Disorders	Auricular keloids are benign fibroproliferative growths characterized by excessive deposition of extracellular matrix components (primarily type I and type III collagen) extending beyond the boundaries of the original wound or inflammatory site on the auricle. The pathogenesis involves dysregulation of the wound healing process, specifically an imbalance between collagen synthesis and degradation, with upregulation of transforming growth factor-beta (TGF-beta), platelet-derived growth factor (PDGF), and insulin-like growth factor-1 (IGF-1) signaling in keloid fibroblasts. Keloid fibroblasts demonstrate increased proliferative capacity, resistance to apoptosis (via upregulation of Bcl-2 and downregulation of p53), and excessive collagen production (up to 20 times normal fibroblast output). The most common precipitating factor for auricular keloids is ear piercing, accounting for 50-75% of cases, followed by otoplasty, burns, trauma, and spontaneous formation (rare). Ear piercing through the lobule is the most common site, but cartilage piercings (helix, tragus) can also trigger keloid formation. A strong genetic predisposition exists, with keloid-prone individuals often having a family history in first-degree relatives; genome-wide association studies have identified susceptibility loci on chromosomes 1q41, 3q22, and 15p21. The auricle is one of the most common sites for keloid formation due to the constant tension on ear piercings from jewelry and the relative immobility of auricular skin.	Keloids overall affect approximately 4.5-16% of the general population, with significantly higher rates in individuals of African descent (6-16%), Hispanic ethnicity (5-10%), and Asian descent (4-8%) compared to Caucasian populations (0.5-2%). Auricular keloids specifically represent approximately 25-30% of all keloid cases. Among individuals with ear piercings, keloid formation occurs in approximately 2.5-5% overall, but in 15-30% of keloid-prone individuals (those with a personal or family history of keloids). The condition is equally common in males and females when adjusted for piercing rates. Peak incidence occurs during the second and third decades of life, correlating with peak piercing rates and hormonal factors (puberty, pregnancy) that may promote keloid growth.	Most commonly develops between ages 10 and 30 years, with peak onset during adolescence and early adulthood, corresponding to peak ear piercing activity. Keloids are rare before puberty and after age 65, suggesting a hormonal influence on keloid biology. During pregnancy, existing keloids may enlarge due to elevated estrogen and progesterone levels, and new keloids may form more readily. There is no absolute age limit, and keloid formation has been reported from infancy to old age. The time from the inciting event (piercing, surgery, trauma) to keloid development ranges from weeks to years, with most forming within 3-12 months.	A progressively enlarging, firm, smooth, rubbery mass at the site of prior ear piercing, trauma, or surgery is the typical presentation. The keloid extends beyond the original wound margins, distinguishing it from a hypertrophic scar. Pruritus is reported in 50-70% of patients and can be the most distressing symptom. Pain or tenderness, particularly with pressure from telephones, headsets, or sleeping on the affected side, is common. The keloid surface is typically shiny, taut, and may be hyperpigmented (darker than surrounding skin) or erythematous. Auricular keloids can achieve significant size, with some earlobe keloids growing to several centimeters in diameter, causing cosmetic disfigurement and functional problems. A dumbbell or mushroom configuration may develop when a keloid grows on both sides of an earlobe piercing, connected through the piercing tract.	Auricle (pinna): earlobe most commonly, followed by helix, antihelix, tragus; skin and subcutaneous tissue	Clinical diagnosis based on characteristic appearance of a firm, raised, well-circumscribed mass extending beyond the original wound margins at a typical auricular location. Differentiation from hypertrophic scar (confined to wound margins, often regresses spontaneously over 12-18 months) is essential for treatment planning. Excisional biopsy with histopathologic examination may be performed for atypical lesions, revealing thick, randomly oriented hyalinized collagen bundles with a paucity of elastin fibers, increased mucin deposition, and a relatively acellular central zone. Ultrasound can characterize the depth and vascularity of the lesion and aid in treatment planning. Dermoscopy may reveal characteristic features including a shiny white background with red areas representing blood vessels. Photography with standardized views is important for documenting baseline size and monitoring treatment response. In rare cases, dermatofibrosarcoma protuberans or other soft tissue tumors must be excluded, particularly for rapidly growing or recurrent lesions.	Multimodal therapy combining surgical excision with adjunctive treatment yields the best outcomes, as excision alone has a recurrence rate of 45-100%. The current gold-standard approach is surgical excision followed by immediate postoperative intralesional corticosteroid injection: triamcinolone acetonide 10-40 mg/mL injected into the wound margins at the time of closure, repeated every 3-4 weeks for 3-6 sessions. Pressure therapy using custom-fitted pressure earrings (Zimmer clip or similar devices) applied for 8-24 hours daily for 6-12 months provides continuous mechanical compression. Silicone gel sheeting applied for 12-24 hours daily for 3-6 months flattens and softens the scar. Intralesional 5-fluorouracil (5-FU) 50 mg/mL alone or combined with triamcinolone (in a ratio of 9:1 or 3:1) injected at 0.1 mL per cm of scar every 1-2 weeks for 8-12 sessions has shown recurrence rates of 19-28%. Adjuvant radiation therapy (electron beam or superficial X-ray) delivering 12-20 Gy in 3-4 fractions beginning within 24-48 hours of excision reduces recurrence to 10-20%. Cryotherapy with liquid nitrogen applied for two 10-30 second freeze-thaw cycles every 3-4 weeks can reduce keloid volume but carries a risk of hypopigmentation. Laser therapy (585 nm pulsed dye laser or 1064 nm Nd:YAG) can reduce erythema, volume, and symptoms.	Recurrence is the primary challenge in auricular keloid management. Excision alone without adjunctive therapy has an unacceptably high recurrence rate of 45-100%. Combined excision with intralesional corticosteroids reduces recurrence to 25-50%. The most effective multimodal approaches (excision plus radiation, or excision plus 5-FU plus corticosteroids plus pressure therapy) achieve recurrence rates of 10-25%. Patient satisfaction with combined therapy is reported at 70-85%. Keloids do not undergo malignant transformation. Psychological impact can be significant, particularly in visible locations like the ear, and cosmetic concerns are a major driver of treatment-seeking behavior. Patients with a strong family history of keloids and those with multiple previous recurrences have the highest risk of treatment failure. Prevention in keloid-prone individuals includes avoidance of elective ear piercings and immediate prophylactic treatment of any unavoidable auricular wounds.	L91.0
02	2	Bullous Myringitis	External Ear Disorders	Bullous myringitis is an inflammatory condition characterized by the formation of hemorrhagic or serous bullae (fluid-filled blisters) on the tympanic membrane and adjacent deep external auditory canal skin. The condition was historically attributed to viral etiologies (influenza, paramyxovirus), but contemporary evidence suggests that bacterial pathogens are the primary cause in most cases, with Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolated from bullae aspirates in 50-70% of cases, the same organisms responsible for acute otitis media. Mycoplasma pneumoniae was previously considered a major cause but is now thought to account for fewer than 10% of cases. The pathogenesis involves infection of the tympanic membrane epithelium (the outer keratinized squamous layer), with the inflammatory response causing subepithelial fluid accumulation that separates the epithelial layer from the fibrous middle layer, forming bullae. The condition frequently coexists with acute otitis media (concurrent middle ear effusion in 50-70% of cases), supporting the theory that it represents a variant of acute otitis media with particular tympanic membrane involvement rather than a completely separate entity. Seasonal distribution parallels that of upper respiratory infections and acute otitis media, with peak incidence in winter months. Some cases are associated with concurrent upper respiratory tract infections or influenza-like illness.	Relatively uncommon as an isolated diagnosis, with an estimated incidence of 1-2% of all acute ear infections. Historically, bullous myringitis was considered more common, but improved diagnostic criteria have narrowed the definition. The condition represents approximately 5-10% of acute otitis media presentations when specifically sought on otoscopy. True incidence is likely underestimated because mild cases with small bullae may be missed or classified simply as acute otitis media. Seasonal peaks in winter and early spring mirror the epidemiology of respiratory infections and acute otitis media. There is no significant gender predilection. The condition is more commonly diagnosed in primary care and pediatric settings than in otolaryngology clinics.	Can occur at any age but is most common in children aged 2-8 years, reflecting the peak incidence of acute otitis media in this age group. Adults are less frequently affected but can develop the condition at any age, particularly during upper respiratory infections or influenza epidemics. Elderly patients are occasionally affected, and cases associated with Mycoplasma pneumoniae infection tend to occur in adolescents and young adults (ages 10-30 years), corresponding to the peak age group for Mycoplasma respiratory infections. There is no significant age-related difference in clinical severity or outcomes.	Acute, severe otalgia (ear pain) is the hallmark symptom and is typically more intense than in uncomplicated acute otitis media, often causing significant distress particularly in young children. The pain is sharp, deep, and may radiate to the temporal region or jaw. Bloody (serosanguinous) otorrhea occurs when bullae rupture, which is characteristic of the condition and often provides dramatic pain relief. Hearing loss is present in the majority of patients, typically a mild-to-moderate conductive hearing loss (15-30 dB) from the bullae themselves and any concurrent middle ear effusion. Aural fullness and pressure are commonly reported. Systemic symptoms including low-grade fever, malaise, and concurrent upper respiratory symptoms (rhinorrhea, cough) are present in 50-60% of cases. On otoscopy, one or more hemorrhagic or serous bullae are visible on the tympanic membrane surface, ranging from small (2-3 mm) to large enough to fill the entire visualized field, and may extend to the adjacent deep canal skin.	Tympanic membrane (lateral surface, squamous epithelium); deep external auditory canal skin; middle ear (concurrent acute otitis media in 50-70% of cases)	Otoscopic examination is the primary diagnostic tool, revealing characteristic fluid-filled bullae on the tympanic membrane surface. Bullae appear as rounded, raised, translucent or hemorrhagic vesicles that may be single or multiple, ranging from amber (serous) to dark red (hemorrhagic). Pneumatic otoscopy should assess tympanic membrane mobility to evaluate for concurrent middle ear effusion (reduced mobility suggests associated acute otitis media). Tympanometry may show a Type B or Type C pattern when middle ear effusion is present. Audiometry reveals conductive hearing loss correlating with the degree of tympanic membrane compromise and middle ear involvement. Aspiration of bullae fluid (myringotomy with culture) is not routinely performed but can identify the causative organism for research purposes or refractory cases. Mycoplasma pneumoniae serology (IgM antibodies) or PCR may be considered when Mycoplasma is suspected clinically (concurrent atypical pneumonia). In recurrent or atypical cases, granular myringitis, tympanic membrane cholesteatoma, or middle ear neoplasm should be considered in the differential diagnosis.	Oral antibiotics targeting the same organisms as acute otitis media are recommended given the high rate of concurrent bacterial infection: amoxicillin 80-90 mg/kg/day in children (divided into 2-3 doses) or 875 mg twice daily in adults for 10 days is first-line therapy. For penicillin-allergic patients or treatment failures, amoxicillin-clavulanate 90 mg/kg/day (amoxicillin component) in children or 875/125 mg twice daily in adults, or azithromycin 10 mg/kg day 1 then 5 mg/kg/day for days 2-5. Analgesic therapy is essential given the severity of pain: ibuprofen 10 mg/kg every 6-8 hours in children or 400-600 mg every 6-8 hours in adults, combined with acetaminophen 15 mg/kg every 4-6 hours in children or 500-1000 mg every 6 hours in adults for multimodal pain control. Topical analgesic drops containing antipyrine/benzocaine (Auralgan) or 2% lidocaine may provide additional local pain relief applied to the tympanic membrane. Needle aspiration or myringotomy of large, tense bullae provides immediate pain relief and may be performed in the office under topical phenol anesthesia. Topical antibiotic drops (ciprofloxacin 0.3%/dexamethasone 0.1%) are applied after bulla rupture or aspiration to prevent secondary infection, 4 drops twice daily for 7 days. Warm compresses applied to the affected ear provide additional comfort.	Excellent prognosis with complete resolution in the vast majority of patients within 7-14 days. Bullae typically rupture spontaneously within 24-48 hours, often with dramatic pain relief. Hearing returns to baseline once the bullae resolve and any concurrent middle ear effusion clears, usually within 2-4 weeks. Complications are uncommon and include secondary bacterial infection of ruptured bullae, tympanic membrane perforation (which almost always heals spontaneously within 4-6 weeks), and rarely, granular myringitis if the tympanic membrane epithelium fails to regenerate normally. Sensorineural hearing loss has been reported in rare cases, particularly those associated with Mycoplasma pneumoniae, but is uncommon (<5%). Recurrence is unusual and should prompt evaluation for underlying eustachian tube dysfunction or immune deficiency. The condition does not lead to chronic ear disease in the vast majority of patients.	H73.019
03	3	Cauliflower Ear	External Ear Disorders	Cauliflower ear (auricular hematoma with subsequent fibroneocartilage formation) results from blunt trauma to the auricle that shears the tightly adherent perichondrium from the underlying elastic cartilage, creating a subperichondrial hematoma. The auricular cartilage, being avascular, depends entirely on the overlying perichondrium for its blood supply via diffusion. When the perichondrium is separated by an expanding hematoma, the intervening cartilage becomes ischemic and undergoes necrosis. If the hematoma is not promptly evacuated, fibroblasts from the perichondrium and surrounding soft tissue invade the organized hematoma, depositing new fibrocartilage (neocartilage) and collagen in a disorganized pattern. This process, termed fibroneocartilage formation, obliterates the normal anatomic contours of the auricle, producing the characteristic thickened, nodular, deformed appearance. The anterior surface of the auricle is most vulnerable because the skin and perichondrium are thinnest and most tightly adherent to the cartilage in this region. Repeated episodes of trauma and hematoma formation, as occurs in contact sports, lead to progressive deformity. Secondary infection of an untreated auricular hematoma (suppurative perichondritis) can accelerate cartilage destruction and worsen the deformity.	Extremely common in contact sports, with prevalence rates of 44-84% among collegiate and professional wrestlers, 40-60% among mixed martial arts (MMA) fighters, and 20-40% among rugby forwards. The condition affects an estimated 5-10% of all contact sport athletes at some point during their careers. Population-wide prevalence data are limited because mild cases may not seek medical attention. In non-athletic contexts, auricular hematoma occurs in approximately 2-5 per 100,000 emergency department visits for facial trauma. Males are affected far more commonly than females (approximately 10:1), reflecting higher participation rates in high-risk contact sports.	Most commonly occurs in adolescents and young adults aged 15-35 years, corresponding to peak participation in contact sports such as wrestling, boxing, MMA, rugby, and judo. The condition can occur at any age with appropriate traumatic mechanism, including accidental falls, motor vehicle accidents, and physical assault. Pediatric cases in young wrestlers (ages 10-14) are well documented. Cumulative deformity worsens with continued sport participation, so severe cauliflower ear is typically seen in older, more experienced athletes. Occupational cases may occur in law enforcement and military personnel.	Acute auricular hematoma presents with rapid-onset swelling, ecchymosis, and fluctuance of the anterior auricular surface, typically within hours of the traumatic event. Pain ranges from mild to moderate, with tenderness on palpation and a sensation of fullness or pressure. The normal anatomic landmarks of the antihelix, scaphoid fossa, and triangular fossa become obscured by the expanding hematoma. If untreated, the acute hematoma organizes over 7-10 days, transitioning from a fluctuant collection to a firm, fibrotic mass. Established cauliflower ear deformity is characterized by a thickened, irregular, nodular auricle with loss of normal contours, a pale or discolored appearance, and a firm, non-tender consistency. Hearing is generally unaffected unless the deformity causes mechanical obstruction of the EAC or concurrent canal injury is present.	Auricle (pinna); auricular cartilage and perichondrium; external auditory canal (if deformity causes secondary obstruction)	Clinical diagnosis based on history of auricular trauma and physical examination revealing a fluctuant or firm swelling of the anterior auricular surface with loss of normal contour. Aspiration of the collection with an 18-gauge needle confirms the diagnosis when serosanguinous or hemorrhagic fluid is obtained. Ultrasound (high-frequency linear probe, 12-15 MHz) can accurately characterize the hematoma size, depth, and distinguish acute hematoma from organized fibrotic tissue or abscess. CT or MRI imaging is generally unnecessary for isolated auricular hematoma but may be indicated when concurrent temporal bone fracture or intracranial injury is suspected. In the chronic established deformity, the diagnosis is clinical based on the characteristic appearance and history. If abscess is suspected (fever, increasing erythema, fluctuance with purulent drainage), aspiration with Gram stain and culture is essential.	Acute auricular hematoma requires urgent drainage within 24-72 hours to prevent permanent deformity. Needle aspiration using an 18-gauge needle under sterile conditions may be attempted for small, acute hematomas, but incision and drainage is more definitive for larger or recurrent collections. A curvilinear incision along the antihelix is made, the hematoma is evacuated, and through-and-through mattress bolster sutures (dental rolls or silicone bolsters) using 4-0 nylon are placed to re-approximate the perichondrium to cartilage and prevent reaccumulation. Alternatively, quilting sutures without bolsters may be used. A compressive mastoid-type dressing is applied for 5-7 days. Prophylactic antibiotics covering skin flora and Pseudomonas are administered, such as cephalexin 500 mg four times daily or ciprofloxacin 500 mg twice daily for 7-10 days, given the risk of perichondritis. For established cauliflower ear deformity, surgical correction (otoplasty) involves excision of fibroneocartilage and recontouring using autologous cartilage grafts if needed, though results are often suboptimal for severely deformed ears. Prevention with properly fitted headgear (wrestling ear guards) is the most effective strategy.	Prognosis for preventing deformity is excellent when drainage is performed within 24 hours of injury, with successful prevention of cauliflower ear in more than 90% of promptly treated cases. Delayed treatment beyond 48-72 hours significantly reduces the likelihood of preventing permanent deformity, as fibroblast proliferation and collagen deposition begin within 2-3 days. Recurrence of hematoma after drainage occurs in 10-20% of cases and may require repeat drainage. Infection (suppurative perichondritis) complicates 3-8% of auricular hematomas and dramatically worsens cartilage destruction and subsequent deformity. Once established cauliflower ear deformity has formed, it is permanent without surgical correction, and even surgical reconstruction rarely achieves a completely normal appearance. Athletes who return to contact sports without protective headgear have a high likelihood of recurrent trauma and progressive deformity.	M95.10
04	4	Cerumen Impaction	External Ear Disorders	Cerumen (earwax) impaction occurs when accumulated cerumen fully occludes the external auditory canal, causing symptoms and/or preventing adequate examination of the tympanic membrane. Cerumen is a normal secretion produced by ceruminous glands (modified apocrine sweat glands) and sebaceous glands in the cartilaginous outer third of the EAC, composed of a mixture of desquamated keratinocytes (60%), saturated and unsaturated long-chain fatty acids, squalene, cholesterol, and antimicrobial peptides (lysozyme, lactoferrin) that provide a protective acidic (pH 6.1) barrier. The normal self-cleaning mechanism relies on lateral epithelial migration from the tympanic membrane outward (at approximately 0.05 mm/day) combined with jaw movement during mastication, which propels cerumen toward the canal entrance. Impaction results when this self-cleaning mechanism is disrupted by factors including: narrow or tortuous ear canals (anatomic variation or exostoses), excessive cerumen production (genetic, hormonal), insertion of cotton swabs or hearing aids that push cerumen deeper, canal obstruction (exostoses, osteomas, canal stenosis), increased keratin content in elderly patients producing harder, drier cerumen, and hearing aid or earplug use that blocks normal outward migration. Cerumen exists in two phenotypic forms determined by the ABCC11 gene: wet cerumen (golden-brown, sticky; predominant in Caucasian and African populations) and dry cerumen (gray, flaky; predominant in East Asian and Native American populations).	One of the most common conditions in otologic practice, affecting approximately 6% of the general population at any given time and up to 10% of children. Approximately 12 million people seek medical care for cerumen impaction annually in the United States, generating over 8 million cerumen removal procedures per year. Prevalence is significantly higher in certain populations: 30-40% of elderly individuals in care facilities, 30-36% of patients with intellectual disabilities, 20-25% of hearing aid users, and 10-15% of children. The condition accounts for approximately 25% of all primary care ear-related visits. Males are slightly more frequently affected than females. Annual healthcare costs attributable to cerumen impaction in the US are estimated at $47 million for office visits alone.	Occurs at all ages, from neonates to the elderly. Children aged 2-10 years are commonly affected due to narrower ear canals and difficulty with hygiene. A second peak occurs in patients over 65 years, where cerumen becomes drier and harder due to decreased glandular secretion, and the ear canal narrows with aging cartilage changes. Hearing aid use in the elderly population further increases impaction rates. In neonates, vernix caseosa may mimic cerumen impaction. Occupational exposure to dust and debris (construction workers, miners) increases impaction risk in working-age adults.	Conductive hearing loss is the most common symptom, typically mild (5-15 dB) but occasionally significant (up to 40 dB) when the canal is completely occluded, and often perceived as sudden when the final increment of cerumen completes the occlusion (e.g., after swimming when cerumen swells with water absorption). Aural fullness, pressure, or a sensation of ear blockage is reported by the majority of patients. Tinnitus (ringing, buzzing, or humming) accompanies hearing loss in 30-40% of cases. Otalgia (ear pain) may occur from pressure of impacted cerumen against the canal walls or tympanic membrane, and pain during jaw movement can mimic temporomandibular joint dysfunction. Pruritus (itching) is common, particularly with dry cerumen types. Dizziness or vertigo may rarely result from cerumen impaction, possibly from pressure changes on the tympanic membrane or caloric stimulation by hard cerumen abutting the canal wall near the tympanic membrane. Cough (Arnold nerve reflex) may be triggered by cerumen stimulating the auricular branch of the vagus nerve.	External auditory canal; tympanic membrane (secondary effects from pressure or inability to examine)	Otoscopic examination reveals a mass of cerumen partially or completely occluding the EAC, preventing visualization of the tympanic membrane. The cerumen may range from soft and golden-brown to hard, dark, and rock-like depending on age and composition. Audiometry should be performed before and after removal if hearing loss is a concern, typically showing a low-frequency conductive hearing loss pattern. Tympanometry may show a flat (Type B) tympanogram when cerumen fully occludes the canal, which normalizes after removal (a useful tool if middle ear effusion must be excluded). After removal, complete otoscopic examination of the tympanic membrane is essential to exclude underlying pathology (perforation, cholesteatoma, middle ear effusion). No imaging or laboratory studies are necessary for uncomplicated cerumen impaction. If the cerumen is hard, adherent, and the tympanic membrane cannot be visualized, cerumenolytic agents should be applied for softening before attempted removal.	Three principal methods exist for cerumen removal, chosen based on cerumen consistency, canal anatomy, and provider expertise. Manual removal under direct otoscopic or microscopic visualization using curettes (Jobson-Horne, Shapleigh), alligator forceps, or right-angle hooks is the most precise method and is preferred for hard, impacted cerumen and when the tympanic membrane status is uncertain. Irrigation (warm water at body temperature 37 degrees Celsius, using a 20-60 mL syringe with a soft catheter tip or electronic pulsed irrigation device) is effective for soft cerumen; contraindicated if tympanic membrane perforation is suspected, tympanostomy tubes are present, or prior mastoid surgery has been performed. Cerumenolytic agents soften hard cerumen prior to removal: docusate sodium 0.5% (Debrox alternative), hydrogen peroxide 3% drops, carbamide peroxide 6.5% (Debrox) 5-10 drops for 15-30 minutes, or sodium bicarbonate 10% drops. Olive oil or mineral oil drops (5 drops at bedtime for 3-5 nights) are gentle softeners for at-home pre-treatment. Microsuction under microscopic visualization is safe and precise, particularly suitable for patients with tympanic membrane perforations, narrow canals, or previous surgery. Post-removal, acidifying drops (acetic acid 2%) may be applied to restore normal canal pH. Patient education on avoiding cotton swab insertion is essential for prevention.	Excellent prognosis following successful cerumen removal, with immediate symptom resolution in more than 95% of cases. Hearing typically returns to baseline immediately after complete removal. Complications of cerumen removal are uncommon (1-5%) and include canal skin abrasion, tympanic membrane perforation (0.01-0.5% with irrigation), otitis externa from irrigation-induced moisture, vertigo from caloric stimulation during irrigation, and vasovagal syncope. Recurrence is the main long-term issue, with 30-40% of patients experiencing repeat impaction within 12 months, particularly in predisposed individuals (hearing aid users, anatomic variants, elderly). Regular professional cleaning every 6-12 months may be recommended for recurrence-prone patients. Self-cleaning with cotton swabs should be strongly discouraged as it worsens impaction. Over-the-counter cerumenolytic drops used prophylactically (weekly) may reduce recurrence frequency.	H61.20
05	5	Contact Dermatitis of the Ear	External Ear Disorders	Contact dermatitis of the ear encompasses both allergic contact dermatitis (ACD, type IV delayed hypersensitivity reaction) and irritant contact dermatitis (ICD) affecting the auricle and external auditory canal. Allergic contact dermatitis is mediated by sensitized T lymphocytes (CD4+ Th1 cells) that recognize hapten-protein conjugates presented by Langerhans cells, triggering an inflammatory cascade upon re-exposure, with a latency period of 24-72 hours. The most common allergens causing auricular ACD include nickel sulfate (the most prevalent contact allergen worldwide, found in earrings, hearing aids, and spectacle frames), cobalt chloride, chromium, neomycin (present in many otic drops), benzocaine, propylene glycol (vehicle in otic preparations), fragrances, and rubber components in hearing aid molds and earplugs. Irritant contact dermatitis results from direct cytotoxic damage to the skin barrier by chemical irritants without prior sensitization, commonly from hearing aid materials, prolonged moisture, antiseptic solutions (chlorhexidine, alcohol), or strong topical medications. The thin skin of the EAC and conchal bowl is particularly susceptible to contactants due to its limited barrier function. Chronic contact dermatitis leads to epidermal thickening (lichenification), fissuring, and secondary bacterial or fungal colonization, perpetuating the inflammatory cycle.	Contact dermatitis is one of the most common dermatologic conditions affecting the ear. Nickel allergy affects approximately 10-15% of the general population (up to 25-30% of women with pierced ears) and is the most common cause of earring-related dermatitis. Hearing aid-related contact dermatitis affects 15-30% of hearing aid users, with acrylates, silicone, and methacrylate being common sensitizers in hearing aid mold materials. Neomycin allergy is present in approximately 10-18% of patients with chronic otitis externa, making it one of the most frequently encountered medication allergies in otologic practice. The overall prevalence of otic topical medication allergy among chronic otitis externa patients is 20-40%. Contact dermatitis of the EAC accounts for approximately 10-15% of all chronic otitis externa cases. Women are affected more frequently than men for earring-related dermatitis due to higher piercing rates.	Can occur at any age, with the pattern depending on the specific allergen. Earring-related nickel dermatitis most commonly presents in adolescents and young women (ages 12-30) following ear piercing. Hearing aid-related contact dermatitis predominantly affects elderly patients (over 65 years) who are the primary hearing aid users. Neomycin and other topical medication allergies can develop at any age but are more common in adults with chronic ear conditions requiring prolonged topical therapy. Occupational contact dermatitis (hairdressers, healthcare workers) follows occupational exposure patterns. Sensitization typically requires prior exposure, so first episodes occur months to years after initial contact with the allergen.	Pruritus is the hallmark symptom and is often intense, leading to scratching that exacerbates the condition. Acute allergic contact dermatitis presents with erythema, edema, vesiculation, and weeping of the affected skin, localized to the area of allergen contact (earlobes from earrings, conchal bowl from hearing aids, EAC from otic drops). The rash typically has well-demarcated borders corresponding to the shape of the contactant. Chronic contact dermatitis manifests as dry, scaly, thickened (lichenified) skin with fissuring, particularly in the retroauricular sulcus and at the EAC entrance. Secondary bacterial infection may cause purulent discharge, crusting, and increased pain. Eczematous changes in the EAC can cause conductive hearing loss from canal wall edema and accumulated debris. A burning sensation may accompany irritant contact dermatitis more than allergic contact dermatitis.	Auricle (earlobe, conchal bowl, helix); external auditory canal; retroauricular sulcus; periauricular skin	Patch testing is the gold standard for identifying the specific causative allergen in suspected allergic contact dermatitis, performed by a dermatologist using standardized allergen panels (TRUE test or extended series). The standard series includes nickel sulfate, neomycin, fragrance mix, balsam of Peru, rubber accelerators, preservatives, and other common allergens, applied on the upper back for 48 hours with readings at 48 and 96 hours. Clinical history correlating symptom onset with specific exposures (new earrings, hearing aid use, otic drops) is essential. Otoscopic examination reveals erythematous, edematous, scaly, or weeping EAC skin, often with a clear demarcation at the point of contact. Skin biopsy is rarely needed but shows spongiotic dermatitis with eosinophils in acute ACD and acanthosis with hyperkeratosis in chronic ACD. Culture of any secondary infection guides antibiotic selection. Serum IgE levels are typically normal (contact dermatitis is a type IV, not type I, reaction). KOH preparation should be performed to exclude concurrent fungal infection.	Identification and strict avoidance of the causative allergen is the cornerstone of treatment and prevention. For acute flares, moderate-potency topical corticosteroids such as betamethasone valerate 0.1% cream or triamcinolone acetonide 0.1% cream applied twice daily for 2-3 weeks to the auricle, or fluocinolone acetonide 0.01% oil-based drops for EAC involvement. For severe acute reactions, a short course of oral prednisone 40-60 mg daily for 5-7 days with rapid taper may be required. Topical calcineurin inhibitors (tacrolimus 0.1% ointment or pimecrolimus 1% cream twice daily) are useful for maintenance therapy and steroid-sparing management on the thin auricular skin. Emollients and barrier creams (dimethicone-based) protect the skin and restore the epidermal barrier. Antihistamines such as cetirizine 10 mg daily or hydroxyzine 25 mg at bedtime provide symptomatic relief of pruritus. For nickel allergy, switching to hypoallergenic jewelry (titanium, surgical steel, 14k+ gold, or platinum) is essential. Hearing aid-related dermatitis may require refabrication of the mold using a non-sensitizing material (silicone, titanium, or hypoallergenic acrylic). Secondary bacterial infection requires topical or systemic antibiotic treatment.	Excellent prognosis when the causative allergen is identified and successfully avoided, with complete resolution expected within 2-4 weeks of cessation of exposure. Without allergen avoidance, the condition will persist or recur with each exposure. Chronic contact dermatitis that has been present for months to years may take 4-8 weeks to fully resolve even after allergen elimination. Secondary skin changes (lichenification, hyperpigmentation) may persist for months after active inflammation resolves. Approximately 80-90% of patients can identify and avoid their specific triggers with patch testing guidance. Patients sensitized to one allergen have a higher risk of developing sensitivity to other allergens over time (cross-sensitization or polysensitization occurs in 15-20%). Permanent hearing aid-related dermatitis may necessitate bone-anchored hearing devices as an alternative. Quality of life impact is significant but fully reversible with appropriate management.	L23.89

Unlock the full dataset

KEEP EXPLORING

There’s more to discover.

Find another starting point in the dataset library.

Explore all datasets